JO
PCVX icon

John Overdeck’s Vaxcyte PCVX Stock Holding History

John Overdeck’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.9M Buy
273,876
+162,566
+146% +$8.83M 0.01% 1191
2026
Q1 		$6.47M Hold
111,310
– – 0.01% 1765
2025
Q4 		$5.14M Buy
111,310
+3,723
+3% +$167K 0.01% 1707
2025
Q3 		$3.88M Buy
107,587
+20,025
+23% +$663K 0.01% 1654
2025
Q2 		$2.85M Buy
+87,562
New +$2.87M 0.01% 1587
2023
Q2 		– Sell
-238,398
Closed -$8.94M – 3205
2023
Q1 		$8.94M Buy
238,398
+38,239
+19% +$1.62M 0.03% 633
2022
Q4 		$9.6M Buy
+200,159
New +$7.85M 0.03% 572

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

John Overdeck's PCVX Position: Q2 2026 in Review

John Overdeck increased its Vaxcyte (PCVX) stake by 146% in Q2 2026, buying an estimated $8.83M and bringing the position to 273,876 shares worth $15.9M. The position accounts for 0.01% of the portfolio, ranked #1191.

John Overdeck first reported a position in PCVX in Q4 2022 and has held it in 7 quarters since. 330 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • John Overdeck held 273,876 shares of Vaxcyte worth $15.9M as of Q2 2026.
  • John Overdeck bought 162,566 Vaxcyte shares in Q2 2026, an estimated $8.83M.
  • Vaxcyte made up 0.01% of John Overdeck's portfolio in Q2 2026, its #1191 holding.
  • John Overdeck first reported a position in Vaxcyte in Q4 2022 and has held it in 7 quarters since.
  • 330 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.